Psychiatry and Neurology, Neurology · St Petersburg, FL
NPI
1609861798
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
603 7th St S Ste 100
St Petersburg, FL, 33701
Phone (727) 553-7240
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
3,769 services
Medicare patients, 2024
438
Average age 76
Drug cost, 2024
$2.0M
2,235 prescriptions
Company payments, 2025
$1,451
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel B Bell was code 99215 (office e&m - established), 657 times for 353 patients. In total Daniel B Bell billed 3,769 services in 47 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 657 | 353 | $128.11 | $84K |
| 97110 PT Treatment | Office | 370 | 19 | $17.46 | $6,462 |
| 96137 Behavioral Health Services | Office | 178 | 34 | $28.51 | $5,075 |
| 96133 Behavioral Health Services | Office | 176 | 44 | $67.48 | $12K |
| 97140 PT Treatment | Office | 166 | 15 | $14.16 | $2,351 |
| 99205 Office E&M - New | Office | 137 | 137 | $149.28 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 113 | 43 | $92.66 | $10K |
| 95813 Neurologic | Office | 91 | 90 | $329.15 | $30K |
| 96132 Behavioral Health Services | Office | 44 | 44 | $96.75 | $4,257 |
| 96116 Behavioral Health Services | Office | 44 | 44 | $64.49 | $2,838 |
| 96136 Behavioral Health Services | Office | 35 | 35 | $31.74 | $1,111 |
| 95885 Electrical Nerve Conductivity | Office | 33 | 33 | $46.04 | $1,519 |
| 95819 Neurologic | Facility | 32 | 31 | $43.38 | $1,388 |
| 99223 Hospital E&M - Initial | Facility | 32 | 31 | $135.25 | $4,328 |
| 95913 Electrical Nerve Conductivity | Office | 18 | 18 | $216.86 | $3,903 |
By year: 2022 $253K for 4,781 services; 2023 $239K for 4,264 services; 2024 $211K for 3,769 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel B Bell prescribed most often to Medicare patients was Memantine Hcl, with 239 prescriptions and refills. In total Daniel B Bell wrote 2,235 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 239 | 461 | 59 | $7,176 |
| Gabapentin Generic | 123 | 244 | 35 | $3,301 |
| Levetiracetam Generic | 114 | 290 | 34 | $3,677 |
| Tramadol Hcl Generic | 104 | 110 | 18 | $1,908 |
| Clonazepam Generic | 70 | 89 | 14 | $712 |
| Modafinil Generic | 66 | 76 | 14 | $21K |
| Primidone Generic | 62 | 172 | 23 | $1,413 |
| Donepezil Hcl Generic | 62 | 148 | 20 | $1,231 |
| Clopidogrel Clopidogrel Bisulfate | 60 | 154 | 17 | $878 |
| Rivastigmine Generic | 56 | 78 | 11 | $6,294 |
| Alprazolam Generic | 55 | 84 | 15 | $364 |
| Rivastigmine Rivastigmine Tartrate | 53 | 114 | 13 | $4,785 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 47 | 108 | 16 | $1,686 |
| Duloxetine Hcl Generic | 45 | 116 | 16 | $1,819 |
| Sumatriptan Succinate Generic | 42 | 63 | Under 11 | $679 |
Brand drugs: - claims; generic drugs: 2,028 claims; opioid claims: 120.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel B Bell $1,451 ($1,451 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $408.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $408 |
| Pfizer Inc. PFE | 10 | $216 |
| Amgen Inc. AMGN | 4 | $136 |
| Celgene Corporation BMY | 5 | $90.99 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $84.41 |
| Lundbeck LLC | 3 | $79.79 |
| Ge Healthcare GEHC | 3 | $66.37 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $65.56 |
| UCB, Inc. UCB.BR | 3 | $64.37 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $62.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.